Consolidated Statement of Changes in Net Equity

For details see Note (34) Equity.

Consolidated statement of changes in net equity – 2024

€ million

 

Equity capital

 

Capital reserves

 

Retained earnings

 

Gains/losses recognized in equity

 

Equity attributable to share­holders of Merck KGaA, Darmstadt, Germany

 

Non-controlling interests

 

Total equity

Jan. 1, 2024

 

565

 

3,814

 

20,228

 

2,073

 

26,680

 

75

 

26,754

Profit after tax

 

–

 

–

 

2,777

 

–

 

2,777

 

9

 

2,786

Gains/losses recognized in equity

 

–

 

–

 

121

 

1,375

 

1,496

 

–

 

1,496

Comprehensive income

 

–

 

–

 

2,897

 

1,375

 

4,272

 

9

 

4,282

Dividend payments

 

–

 

–

 

-284

 

–

 

-284

 

-9

 

-293

Capital increases

 

–

 

–

 

–

 

–

 

–

 

1

 

1

Profit transfer to/from E. Merck KG, Darmstadt, Germany, including changes in reserves

 

–

 

–

 

-755

 

–

 

-755

 

–

 

-755

Transactions with no change of control

 

–

 

–

 

–

 

–

 

–

 

–

 

–

Change in scope of consolidation/Other1

 

–

 

–

 

2

 

–

 

2

 

–

 

2

Dec. 31, 20241

 

565

 

3,814

 

22,087

 

3,448

 

29,914

 

75

 

29,989

1

Previous-year figures have been adjusted owing to the finalization of the purchase price allocation in connection with the acquisitions of Mirus Bio LLC, USA, Unity-SC SAS, France, as well as Hub Organoids Holding B.V., Netherlands (see Note (6) Acquisitions and divestments).
Consolidated statement of changes in net equity – 2025

€ million

 

Equity capital

 

Capital reserves

 

Retained earnings

 

Gains/losses recognized in equity

 

Equity attributable to share­holders of Merck KGaA, Darmstadt, Germany

 

Non-controlling interests

 

Total equity

Jan. 1, 2025

 

565

 

3,814

 

22,087

 

3,448

 

29,914

 

75

 

29,989

Profit after tax

 

–

 

–

 

2,608

 

–

 

2,608

 

7

 

2,615

Gains/losses recognized in equity

 

–

 

–

 

382

 

-3,273

 

-2,892

 

-4

 

-2,896

Comprehensive income

 

–

 

–

 

2,990

 

-3,273

 

-283

 

3

 

-281

Dividend payments

 

–

 

–

 

-284

 

–

 

-284

 

-10

 

-294

Capital increases

 

–

 

–

 

–

 

–

 

–

 

–

 

–

Profit transfer to/from E. Merck KG, Darmstadt, Germany, including changes in reserves

 

–

 

–

 

-754

 

–

 

-754

 

–

 

-754

Transactions with no change of control

 

–

 

–

 

–

 

–

 

–

 

–

 

–

Change in scope of consolidation/Other

 

–

 

–

 

–

 

–

 

–

 

–

 

–

Dec. 31, 2025

 

565

 

3,814

 

24,039

 

174

 

28,592

 

68

 

28,660

Related Links

Share this page: